Helicobacter pylori-induced matrix metallopeptidase-10 promotes gastric bacterial colonization and gastritis

Yi-Pin Lv1, Ping Cheng1, Jin-Yu Zhang1

  • 1National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.

Science Advances
|April 6, 2019
PubMed

Insights

Matrix metalloproteinase-10 (MMP-10) promotes Helicobacter pylori colonization and gastritis by affecting immune cells and epithelial barrier function. Reducing MMP-10 could be a therapeutic strategy against H. pylori infection.

Area of Science:

  • Gastroenterology
  • Immunology
  • Molecular Biology

Background:

  • Helicobacter pylori infection is a major cause of gastritis and other gastric pathologies.
  • The interplay between gastric epithelium and the immune system is crucial in H. pylori-associated diseases.

Purpose of the Study:

  • To investigate the role of Matrix metalloproteinase-10 (MMP-10) in H. pylori infection and associated gastric pathology.
  • To elucidate the mechanisms by which MMP-10 influences bacterial colonization and inflammation.

Main Methods:

  • Analysis of MMP-10 levels in human gastric mucosa.
  • Studies in genetically modified mice (IL-22-/-, MMP-10-/-, and combined knockouts) to assess H. pylori colonization and inflammation.
  • Investigation of the MMP-10-CXCL16 axis and its effect on CD8+ T cell migration.
  • Assessment of protein expression (Reg3a, E-cadherin, zonula occludens-1) under MMP-10 influence.

Main Results:

  • MMP-10 is elevated in H. pylori-infected gastric mucosa and produced by epithelial cells.
  • MMP-10 deficiency or IL-22 deficiency attenuated H. pylori colonization and inflammation in mice.
  • MMP-10 promotes CD8+ T cell influx via the MMP-10-CXCL16 axis.
  • MMP-10 downregulates Reg3a, E-cadherin, and zonula occludens-1, impairing host defense.

Conclusions:

  • MMP-10 plays a significant pro-colonization and pro-inflammation role in H. pylori infection.
  • MMP-10 facilitates H. pylori persistence and exacerbates gastritis by compromising epithelial barrier function and modulating immune cell infiltration.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.2K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
2.2K
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
59.5K
The Colonization of Land02:22

The Colonization of Land

Changes in the environment of the early Earth drove the evolution of organisms. As prokaryotic organisms in the oceans began to photosynthesize, they produced oxygen. Eventually, oxygen saturated the oceans and entered the air, resulting in an increase in atmospheric oxygen concentration, known as the oxygen revolution approximately 2.3 billion years ago. Therefore, organisms that could use oxygen for cellular respiration had an advantage. More than 1.5 years ago, eukaryotic cells and...
37.5K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K